Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddy’s receives EIR for API Cuernavaca plant in Mexico

Date: 10-04-2018

Dr. Reddy’s Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API Cuernavaca plant in Mexico.

Earlier in March 2018, USFDA had completed audit at company’s API Hyderabad plant I at Jinnaram Mandal, Medak District, Telangana.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.